Residency · Residency · Urology
Partial Nephrectomy: Principles and Technique
Overview
Partial nephrectomy involves removing a renal tumor while preserving as much healthy kidney tissue as possible. This nephron-sparing surgery is indicated in various clinical scenarios and can be performed through open, laparoscopic, or robotic approaches. Key considerations include managing warm ischemia time to minimize renal injury, employing effective renorrhaphy techniques to reconstruct the kidney, and understanding the differing outcomes between imperative and elective cases.
Indications
Partial nephrectomy is indicated under both absolute (imperative) and relative (elective) circumstances. Absolute indications include patients with a solitary kidney—whether anatomical or functional—bilateral renal masses, pre-existing chronic kidney disease (CKD), and hereditary renal cell carcinoma (RCC) syndromes such as von Hippel-Lindau (VHL), hereditary papillary RCC, or Birt-Hogg-Dubé syndrome, where there is a high risk of future tumors. Relative or elective indications apply to patients with a normal contralateral kidney who have a T1a renal mass (4 cm or less), which is considered the standard of care. Partial nephrectomy is increasingly recommended for T1b masses (4-7 cm) when technically feasible, as well as for multifocal or bilateral tumors and in patients with conditions that threaten future renal function, such as diabetes, hypertension, or recurrent kidney stones.
According to guidelines from the American Urological Association (AUA) and the National Comprehensive Cancer Network (NCCN), partial nephrectomy is the preferred treatment for clinical T1a renal masses when technically possible, regardless of the status of the opposite kidney. For T1b tumors, partial nephrectomy is recommended when feasible, with oncologic outcomes comparable to radical nephrectomy. For larger tumors greater than 7 cm (T2), partial nephrectomy may be considered in select cases at experienced centers, particularly when imperative indications exist.
Surgical Approaches
Open partial nephrectomy (OPN) is performed through a flank or subcostal incision, using either a retroperitoneal or transperitoneal approach. This method provides excellent tactile feedback and facilitates complex renal reconstruction. Historically, OPN was the gold standard but its use has declined. It remains preferred for very complex tumors characterized by high RENAL or PADUA scores, large tumors, or cases involving inferior vena cava (IVC) thrombus.
Laparoscopic partial nephrectomy (LPN) is technically demanding with a steep learning curve and typically results in longer warm ischemia times compared to open or robotic approaches. Consequently, it has largely been replaced by robotic-assisted techniques.
Robot-assisted partial nephrectomy (RAPN) is now the most common approach in the United States and Europe. It offers advantages such as three-dimensional magnification, wristed instruments for enhanced dexterity, and precise dissection and suturing capabilities. These features allow for complex renorrhaphy within acceptable ischemia times. The learning curve for RAPN ranges from 25 to 50 cases to achieve competency. Oncologic outcomes are comparable to OPN, with the added benefits of lower blood loss and shorter recovery times.
Tumor Complexity Scoring
The RENAL nephrometry score is a standardized system used to quantify tumor complexity based on five components. The "R" stands for radius, measuring the maximal tumor diameter in centimeters: 1 point for tumors ≤4 cm, 2 points for 4-7 cm, and 3 points for >7 cm. "E" assesses the exophytic or endophytic nature of the tumor, with 1 point if ≥50% of the tumor is exophytic, 2 points if less than 50% is exophytic, and 3 points if the tumor is entirely endophytic. "N" denotes the nearness of the tumor to the collecting system or sinus in millimeters: 1 point if ≥7 mm, 2 points if 4-7 mm, and 3 points if ≤4 mm. "A" is an anterior/posterior descriptor, labeled as "a," "p," or "x" if indeterminate. "L" refers to the tumor’s location relative to the polar lines of the kidney: 1 point if entirely above or below a polar line, 2 points if crossing one polar line, and 3 points if crossing the axial midline or located entirely between polar lines. A hilar location modifier "h" is added if applicable. The total RENAL score ranges from 4 to 12, with 4-6 indicating low complexity, 7-9 moderate, and 10-12 high complexity.
| RENAL Component | 1 Point | 2 Points | 3 Points |
|---|---|---|---|
| R (Radius/size) | ≤4 cm | 4-7 cm | >7 cm |
| E (Exophytic/endophytic) | ≥50% exophytic | <50% exophytic | Entirely endophytic |
| N (Nearness to collecting system) | ≥7 mm | 4-7 mm | ≤4 mm |
| A (Anterior/posterior) | Descriptor: a, p, or x (not scored) | ||
| L (Location relative to polar lines) | Entirely above/below polar line | Crosses one polar line | Crosses axial midline or between polar lines |
| Total Score | Complexity |
|---|---|
| 4-6 | Low |
| 7-9 | Moderate |
| 10-12 | High |
The PADUA score is a similar system that incorporates comparable tumor characteristics; higher PADUA scores correlate with increased risks of complications and positive surgical margins.
Clinically, higher complexity scores predict longer ischemia times, increased complication rates, greater estimated blood loss (EBL), and a higher risk of positive surgical margins. These scores assist in patient counseling, surgical approach selection, and operative planning. Tumors with very high complexity may warrant radical nephrectomy or referral to specialized centers.
Surgical Steps (RAPN)
Patient positioning for robot-assisted partial nephrectomy typically involves a lateral decubitus position at 45 degrees or a full flank position, with the kidney bridge elevated if lateral positioning is used to optimize exposure. Port placement generally includes four to five ports: one for the camera, three for robotic arms, and one for the assistant. The configuration depends on the tumor’s laterality and location.
The surgical procedure begins with mobilization of the colon by reflecting it medially along the line of Toldt. Next, the renal hilum is dissected to identify the renal artery and vein, preparing vessel loops or bulldog clamps for vascular control. Intraoperative ultrasound is employed to confirm tumor margins and depth, identify any satellite lesions, and guide the resection plane.
Hilar clamping is performed using bulldog clamps on the renal artery, with arterial-only clamping preferred over en-bloc clamping of both artery and vein to reduce ischemic injury. Tumor excision involves circumferential scoring of the renal capsule around the tumor with an adequate margin of 3-5 mm, followed by excision using cold scissors or cautery along the plane between the tumor pseudocapsule and normal parenchyma.
After excision, the tumor bed is inspected for residual tumor, and any open collecting system entries or vessels are clipped or sutured. Renorrhaphy is then performed in two layers. The inner layer consists of a running suture (using 3-0 V-Loc or Monocryl) through the parenchymal bed to close the collecting system and control deep vessels. The outer cortical layer involves horizontal mattress sutures (2-0 V-Loc) placed over bolsters such as Surgicel or Hem-o-lok clips to re-approximate the renal capsule and compress the parenchyma. Hemostatic agents like Floseal or Surgicel are applied in the tumor bed to enhance hemostasis.
Following renorrhaphy, the bulldog clamps are released to assess for bleeding. Additional sutures are placed if necessary to control hemorrhage. Finally, the specimen is retrieved in an entrapment bag.
Ischemia Considerations
Warm ischemia time (WIT) refers to the duration during which the renal blood supply is interrupted at body temperature, typically during hilar clamping. The traditional target is to keep WIT under 20-25 minutes, as every minute of ischemia has been considered critical. Ischemia times exceeding 30 minutes are associated with increased risks of acute kidney injury and long-term declines in glomerular filtration rate (GFR). However, recent data suggest that renal functional outcomes depend more on the volume of preserved parenchyma than on ischemia time alone, indicating a continuum rather than a strict cutoff.
Several strategies exist to minimize ischemia. Early unclamping involves performing part or all of the renorrhaphy after releasing the clamp, allowing hemostasis to develop over time. Selective or super-selective clamping targets segmental or interlobar arteries supplying the tumor, preserving blood flow to the remainder of the kidney. Off-clamp or zero ischemia techniques involve tumor resection and reconstruction without any clamping, which requires meticulous hemostasis and results in higher blood loss but avoids ischemic injury. This approach is most feasible for small, exophytic tumors and is increasingly advocated in imperative cases such as solitary kidneys or CKD. Cold ischemia, achieved by applying ice slush around the kidney during open surgery, provides protective hypothermia that extends safe ischemia time to approximately 35-40 minutes but is not practical in laparoscopic or robotic approaches.
Postoperative renal function is influenced primarily by the volume of preserved parenchyma, followed by preoperative GFR, ischemia time, and patient factors such as age and comorbidities. Even warm ischemia times of 25-30 minutes may be acceptable if a significant amount of renal tissue is preserved.
Oncologic Outcomes
Positive surgical margins (PSM) occur in approximately 2-8% of partial nephrectomy cases. However, the presence of PSM does not invariably predict tumor recurrence, with recurrence rates ranging from 0 to 10% in these patients. Intraoperative frozen section analysis of the tumor bed is optional and can guide re-excision if necessary. Management of PSM typically involves close surveillance with imaging every 3-6 months initially, while re-excision is rarely required.
Local recurrence rates are low, around 1-3% for T1a tumors, but increase with larger tumors (T1b and above). Most recurrences occur within five years postoperatively. Salvage options include completion nephrectomy, repeat partial nephrectomy, or ablative therapies.
Cancer-specific survival after partial nephrectomy is equivalent to radical nephrectomy for T1a tumors, as demonstrated in multiple large series and the EORTC 30904 trial. For T1b tumors, oncologic outcomes are comparable in well-selected patients. The EORTC 30904 trial remains the only randomized controlled trial comparing partial and radical nephrectomy, showing no difference in cancer-specific survival, though it was underpowered and primarily involved open surgery.
Trifecta and Pentafecta Outcomes
Surgical quality in partial nephrectomy is often benchmarked using the concepts of trifecta and pentafecta outcomes. The trifecta includes achieving negative surgical margins, avoiding major complications (Clavien grade 3 or higher), and maintaining warm ischemia time under 25 minutes. The pentafecta expands on this by also requiring no upstaging of chronic kidney disease (i.e., preservation of GFR) and no tumor recurrence during follow-up. These outcomes are achieved in approximately 50-70% of cases at experienced centers.
Complications
Hemorrhage is the most common major complication, occurring in 1-5% of cases, and may necessitate angioembolization. Delayed pseudoaneurysm or arteriovenous fistula formation typically presents 1-4 weeks postoperatively with gross hematuria or flank pain. Diagnosis is confirmed by CT angiography, and treatment involves selective angioembolization.
Urine leaks occur in 1-5% of patients due to collecting system injury during tumor resection. These leaks usually resolve with ureteral stenting or nephrostomy drainage over days to weeks.
Renal function decline is generally transient, with permanent significant impairment occurring in less than 5% of cases. Conversion to radical nephrectomy is required in 1-5% of surgeries, often due to uncontrollable hemorrhage or positive margins detected on frozen section. Other complications include wound issues, ileus, and venous thromboembolism.
<image>A cross-sectional diagram of a kidney showing a tumor in the mid-pole with the surgical planes for partial nephrectomy. The resection margin around the tumor is highlighted with dashed lines. The renorrhaphy technique is illustrated in a step-by-step inset: step 1 showing the inner layer running suture closing the collecting system and deep vessels, step 2 showing the outer cortical layer with horizontal mattress sutures over bolsters compressing the parenchyma. Bulldog clamps are shown on the renal artery. Hemostatic agent (Floseal) is shown in the tumor bed. Surgical illustration style with color-coded layers.</image>
<image>A visual scoring diagram for the RENAL Nephrometry Score showing an axial and coronal CT image of a kidney with a renal mass. Each component (Radius, Exophytic/endophytic, Nearness to collecting system, Anterior/posterior, Location relative to polar lines) is annotated and scored on the images. A scoring table alongside shows how to calculate the total score and classify complexity as low (4-6), moderate (7-9), or high (10-12). Educational radiology format with CT images and overlaid measurements.</image>
<image>An infographic comparing off-clamp, selective clamping, and full hilar clamping techniques during partial nephrectomy. Each technique is illustrated with a simplified kidney diagram showing which vessels are clamped (if any) and the ischemic zone. Pros and cons are listed for each: off-clamp (no ischemia, higher EBL), selective clamping (reduced ischemia, technically demanding), full hilar clamping (complete hemostasis, whole-kidney ischemia). Estimated WIT and GFR preservation data are included. Clean comparison infographic format.</image>
Clinical Pearls
Partial nephrectomy is the standard treatment for clinical T1a renal masses regardless of the contralateral kidney’s status, as radical nephrectomy for these tumors increases the risk of chronic kidney disease and cardiovascular mortality. The volume of preserved renal parenchyma is the most critical factor determining postoperative renal function, outweighing the impact of warm ischemia time. Intraoperative ultrasound is essential for accurately identifying tumor depth, defining resection margins, and detecting satellite lesions, and should be used routinely. Positive surgical margins after partial nephrectomy carry a low risk of clinical recurrence; therefore, completion nephrectomy is not routinely indicated, and close surveillance is usually sufficient. For complex tumors with a RENAL score of 10 or higher, referral to a high-volume center or an experienced surgeon is advisable, as complication and positive margin rates are significantly elevated. The early unclamping technique, which involves beginning renorrhaphy after inner layer sutures and unclamping before completing the outer layer, can significantly reduce warm ischemia time without compromising hemostasis. Delayed pseudoaneurysm typically presents 1-4 weeks after surgery with gross hematuria and is diagnosed by CT angiography; selective embolization is both diagnostic and therapeutic.
References
- Campbell SC, et al. AUA/SUO Guideline: Renal Mass and Localized Renal Cancer. J Urol. 2021;206(2):209-218
- Kutikov A, Uzzo RG. The RENAL nephrometry score. J Urol. 2009;182(3):844-853
- Thompson RH, et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010;58(3):340-345
- Van Poppel H, et al. A prospective randomized EORTC intergroup phase 3 study comparing radical nephrectomy vs. partial nephrectomy for pT1 RCC (EORTC 30904). Eur Urol. 2011;59(4):543-552
- Autorino R, et al. Robot-assisted partial nephrectomy: multi-institutional outcomes (ROSULA Collaborative Group). Eur Urol. 2019;75(2):226-233
